Teleflex Incorporated

Symbol: TFX

NYSE

204.7

USD

Market price today

  • 32.6749

    P/E Ratio

  • 0.1826

    PEG Ratio

  • 9.64B

    MRK Cap

  • 0.01%

    DIV Yield

Teleflex Incorporated (TFX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.56%

Operating Profit Margin

0.17%

Net Profit Margin

0.10%

Return on Assets

0.04%

Return on Equity

0.07%

Return on Capital Employed

0.07%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO:Mr. Liam J. Kelly
Full-time employees:14500
City:Wayne
Address:550 East Swedesford Road
IPO:1980-03-17
CIK:0000096943

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

General Outlook

When we look at how much money they make before expenses, they keep 0.557% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.166%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.098%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.039% return, is a testament to Teleflex Incorporated's adeptness in optimizing resource deployment. Teleflex Incorporated's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.068%. Furthermore, the proficiency of Teleflex Incorporated in capital utilization is underscored by a remarkable 0.072% return on capital employed.

Stock Prices

Teleflex Incorporated's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $213.28, while its low point bottomed out at $207.14. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Teleflex Incorporated's stock market.

Liquidity Ratios

Analyzing TFX liquidity ratios reveals its financial health of the firm. The current ratio of 251.06% gauges short-term asset coverage for liabilities. The quick ratio (120.13%) assesses immediate liquidity, while the cash ratio (41.58%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio251.06%
Quick Ratio120.13%
Cash Ratio41.58%

Profitability Ratios

TFX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 10.35% underscores its earnings before tax deductions. The effective tax rate stands at 4.73%, revealing its tax efficiency. The net income per EBT, 94.90%, and the EBT per EBIT, 62.18%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 16.65%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin10.35%
Effective Tax Rate4.73%
Net Income per EBT94.90%
EBT per EBIT62.18%
EBIT per Revenue16.65%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.51, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding120
Days of Inventory Outstanding172
Operating Cycle226.89
Days of Payables Outstanding32
Cash Conversion Cycle195
Receivables Turnover6.69
Payables Turnover11.47
Inventory Turnover2.12
Fixed Asset Turnover5.02
Asset Turnover0.40

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 11.42, and free cash flow per share, 9.13, depict cash generation on a per-share basis. The cash per share value, 5.04, showcases liquidity position. A payout ratio of 0.22 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.18, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share11.42
Free Cash Flow per Share9.13
Cash per Share5.04
Payout Ratio0.22
Operating Cash Flow Sales Ratio0.18
Free Cash Flow to Operating Cash Flow Ratio0.80
Cash Flow Coverage Ratio0.31
Short Term Coverage Ratio5.93
Capital Expenditure Coverage Ratio4.98
Dividend Paid and Capex Coverage Ratio3.13
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 23.52%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.39, we discern the balance between debt and equity financing. The long-term debt to capitalization, 27.03%, and total debt to capitalization, 28.08%, ratios shed light on its capital structure. An interest coverage of 5.59 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio23.52%
Debt Equity Ratio0.39
Long Term Debt to Capitalization27.03%
Total Debt to Capitalization28.08%
Interest Coverage5.59
Cash Flow to Debt Ratio0.31
Company Equity Multiplier1.66

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 63.31, provides a glimpse into top-line earnings distributed across each share. Net income per share, 7.58, reflects the portion of profit attributed to each share. The book value per share, 94.53, represents the net asset value distributed per share, while the tangible book value per share, -20.75, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share63.31
Net Income Per Share7.58
Book Value Per Share94.53
Tangible Book Value Per Share-20.75
Shareholders Equity Per Share94.53
Interest Debt Per Share42.81
Capex Per Share-1.95

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 6.57%, indicates top-line expansion, while the gross profit growth, 7.57%, reveals profitability trends. EBIT growth, 1.32%, and operating income growth, 1.32%, offer insights into operational profitability progression. The net income growth, -1.88%, showcases bottom-line expansion, and the EPS growth, -2.07%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth6.57%
Gross Profit Growth7.57%
EBIT Growth1.32%
Operating Income Growth1.32%
Net Income Growth-1.88%
EPS Growth-2.07%
EPS Diluted Growth-1.95%
Weighted Average Shares Growth0.18%
Weighted Average Shares Diluted Growth-0.01%
Dividends per Share Growth-0.01%
Operating Cash Flow Growth49.25%
Free Cash Flow Growth59.42%
10-Year Revenue Growth per Share53.42%
5-Year Revenue Growth per Share18.15%
3-Year Revenue Growth per Share16.01%
10-Year Operating CF Growth per Share97.21%
5-Year Operating CF Growth per Share13.54%
3-Year Operating CF Growth per Share15.78%
10-Year Net Income Growth per Share106.63%
5-Year Net Income Growth per Share72.57%
3-Year Net Income Growth per Share5.15%
10-Year Shareholders Equity Growth per Share103.06%
5-Year Shareholders Equity Growth per Share70.04%
3-Year Shareholders Equity Growth per Share31.71%
10-Year Dividend per Share Growth per Share-0.02%
5-Year Dividend per Share Growth per Share-0.04%
3-Year Dividend per Share Growth per Share0.01%
Receivables Growth8.47%
Inventory Growth8.25%
Asset Growth8.73%
Book Value per Share Growth10.22%
Debt Growth5.15%
R&D Expense Growth0.35%
SGA Expenses Growth7.65%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 13,417,766,540, captures the company's total value, considering both debt and equity. Income quality, 1.43, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 71.90%, indicates the value of non-physical assets, and capex to operating cash flow, -17.91%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value13,417,766,540
Income Quality1.43
Research and Development to Revenue5.19%
Intangibles to Total Assets71.90%
Capex to Operating Cash Flow-17.91%
Capex to Revenue-3.07%
Capex to Depreciation-37.77%
Stock-Based Compensation to Revenue1.06%
Graham Number127.01
Return on Tangible Assets16.84%
Graham Net Net-46.96
Working Capital800,661,000
Tangible Asset Value-975,027,000
Net Current Asset Value-1,684,152,000
Average Receivables426,150,500
Average Payables129,527,000
Average Inventory602,361,500
Days Sales Outstanding54
Days Payables Outstanding36
Days of Inventory On Hand172
ROIC6.55%
ROE0.08%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.14, and the price to book ratio, 2.14, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.21, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 22.45, and price to operating cash flows, 17.92, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.14
Price to Book Ratio2.14
Price to Sales Ratio3.21
Price Cash Flow Ratio17.92
Price Earnings to Growth Ratio0.18
Enterprise Value Multiple9.52
Price Fair Value2.14
Price to Operating Cash Flow Ratio17.92
Price to Free Cash Flows Ratio22.45
Price to Tangible Book Ratio2.64
Enterprise Value to Sales4.51
Enterprise Value Over EBITDA16.41
EV to Operating Cash Flow26.28
Earnings Yield3.04%
Free Cash Flow Yield3.58%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Teleflex Incorporated (TFX) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 32.675 in 2024.

What is the ticker symbol of Teleflex Incorporated stock?

The ticker symbol of Teleflex Incorporated stock is TFX.

What is company IPO date?

IPO date of Teleflex Incorporated is 1980-03-17.

What is company current share price?

Current share price is 204.700 USD.

What is stock market cap today?

The market cap of stock today is 9641902220.000.

What is PEG ratio in 2024?

The current 0.183 is 0.183 in 2024.

What is the number of employees in 2024?

In 2024 the company has 14500.